Bruker | BRKR - Current Assets


Bruker reported $2.1B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
ABB USD 25.46B 116M Mar/2026
Agilent USD 4.76B 148M Mar/2026
Ametek USD 3.14B 117.67M Mar/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Bio-Rad Laboratories USD 2.94B 35.9M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Fujikura JPY 657.58B 51.98B Mar/2026
Furukawa JPY 119.99B 20.97B Dec/2025
General Electric Aerospace USD 40.36B 235M Mar/2026
Hitachi JPY 7.87T 314.77B Mar/2026
Illumina USD 2.74B 551M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Mettler Toledo International USD 1.33B 30.76M Mar/2026
Mitsubishi Electric JPY 3.82T 85.06B Dec/2025
Mitsubishi Heavy Industries JPY 5.44T 676.09B Mar/2026
Myriad Genetics USD 312.8M 19.8M Mar/2026
Nikon Corporation JPY 646.5B 10.98B Mar/2026
Olympus JPY 706.31B 53.66B Mar/2026
Repligen USD 1.16B 23.98M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Smiths GBP 3.06B 1.12B Jun/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Waters USD 3.72B 1.73B Mar/2026